Fosfo-LEF1 (Ser42) Polyklonale Antilichaam

Participates in the Wnt signaling pathway. Activates transcription of target genes in the presence of CTNNB1 and EP300. May play a role in hair cell differentiation and follicle morphogenesis. TLE1, TLE2, TLE3 and TLE4 repress transactivation mediated by LEF1 and CTNNB1. Regulates T-cell receptor alpha enhancer function. Binds DNA in a sequence-specific manner. PIAG antagonizes both Wnt-dependent and Wnt-independent activation by LEF1 (By similarity) . Isoform 3 lacks the CTNNB1 interaction domain and may be an antagonist for Wnt signaling. Isoform 5 transcriptionally activates the fibronectin promoter, binds to and represses transcription from the E-cadherin promoter in a CTNNB1-independent manner, and is involved in reducing cellular aggregation and increasing cell migration of pancreatic cancer cells. Isoform 1 transcriptionally activates MYC and CCND1 expression and enhances proliferation of pancreatic tumor cells.

LEF-1; TCF10; TCF7L3; TCF1ALPHA; Lymphoid enhancer-binding factor 1; T cell-specific transcription factor 1-alpha; TCF1-alpha; LEF1

51176

Q9UJU2

Ser42

Nucleus

Human, Mouse, Rat

Phospho-LEF1 (Ser42)

Unconjugated

KLH conjugated synthetic phosphopeptide derived from human LEF1 around the phosphorylation site of Ser42

WB, IHC-P, IHC-F, IF

Purified by Protein A.

1µg/µl

WB (1:300-5000), IHC-P (1:200-400), IHC-F (1:100-500), IF ()

0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.

Phosphorylation

Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

This antibody will recognize LEF1 (Ser40) in mouse and rat

51176